Contact
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics Signs Agreement for Up to $74.5 Million to Sell Hyperimmune Commercial Products
TO:
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics Signs Agreement for Up to $74.5 Million to Sell Hyperimmune Commercial Products
TO: